Recent Articles

“A majority of likely voters in the most competitive House districts support repealing the Democrats’ health overhaul, according to recent polling data. The figures are one of the sharpest signals yet that Democrats are unlikely to translate their signature legislative achievement into success inside the voting booth. The health bill passed in March is particularly unpopular in the districts that matter most in the Republicans’ effort to retake the House.”

“That interplay has been replicated across the 2010 campaign, with Republicans largely keeping Democrats on the defensive about the Obama presidency’s signature domestic achievement. While clearly secondary to economic concerns, the continuing debate over health care has remained prominent in numerous races for the House and Senate.”

“Just over half of Americans likely to vote in next week’s midterms want the next Congress to repeal this year’s health care overhaul if Republicans gain power on Capitol Hill, according to a new poll, a dramatic rebuke to a sitting president and freshly minted statute. Fifty-one percent of voters most likely to vote support taking the new health care law off the books if the GOP takes the House and Senate, or either, while 41 percent oppose repeal, according to the latest Society for Human Resource Management/National Journal Congressional Connection Poll, conducted with the Pew Research Center.”

Congressmen who voted against the original House health care bill but voted for ObamaCare are in serious trouble in the polls. “Meanwhile, there were five Democrats who flipped from ‘yes’ on the first bill to ‘no’ on final passage. And, by comparison, they’re looking pretty good.”

“But the reality that Democrats hate to discuss – and even some Republicans have been hesitant to fully embrace – is that the party’s signature health care law is what’s turning a bad election year into a disaster of potential history-making proportions.”

“It is true that the tax credits will reduce the effective premium that many households will face for health insurance coverage. However, the key question from a policy perspective is whether the benefits of the Obamacare tax credits outweigh their costs. Since the Families USA report failed to list any of the costs or concerns of the Obamacare tax credits, Heritage will fill the void.”

“Democrats and their media apologists just can’t bring themselves to believe that there is anything substantive behind opposition to Obamacare. And so, instead of engaging in serious argument, they offer up condescending nonsense — such as this New York Times editorial which supposedly debunks the myths being peddled on the campaign trail by candidates trying to stir up opposition to Obamacare.”

“In evaluating this new health care legislation, it’s important to consider not only how
the new law impacts the medical system, health care costs, and quality of care provided but
how the law affects businesses, workers, and the general economy. Unfortunately, as this
policy brief details, this law will have a significant negative impact on the business climate,
will discourage business expansion and job creation, and will slow economic growth.”

“States establishing Obamacare exchanges are making a one-way, lose-lose bet. If Obamacare persists, exchanges will become bloated administrative nightmares. If Obamacare is defeated, states will have wasted time and energy that should have been directed towards that effort. Obamacare is President Obama’s problem. Don’t make it your state’s problem.”

“Patient choice looks to be the first casualty of Obamacare. The new healthcare law gives the federal government unprecedented control over medical decisions. And one bureaucrat in particular looks to be leading the crusade for more public power: Dr. Donald Berwick, the new director of the Centers for Medicare and Medicaid Services (CMS). CMS may be obscure. But it wields enormous influence over the availability of treatments. If CMS decides a treatment isn’t worth its price, public insurance programs like Medicare and Medicaid will stop covering it, and patients will lose access to the treatment.”